Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis

Journal of Rheumatology

Volumn 40, Issue 8, 2013, Pages 1349-1356

  Husted, Janice A ^a   Thavaneswaran, Arane ^b   Chandran, Vinod ^b   Gladman, Dafna D ^b,c  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Comorbidity; Patient reported health; Psoriatic arthritis; Quality of life

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANEMIA; ANXIETY; ARTHROPATHY; ARTICLE; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FIBROMYALGIA; GASTROINTESTINAL DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL COMPONENT SCALE; MENTAL HEALTH; MUSCULOSKELETAL DISEASE; NEOPLASM; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL COMPONENT SCALE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS SEVERITY INDEX; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RATING SCALE; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SHORT FORM 36; SKIN DISEASE;

COMORBIDITY; PATIENT-REPORTED HEALTH; PSORIATIC ARTHRITIS; QUALITY OF LIFE;

ADULT; ANXIETY; ARTHRITIS, PSORIATIC; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FIBROMYALGIA; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; NERVOUS SYSTEM DISEASES; OBESITY; PROSPECTIVE STUDIES; QUALITY OF LIFE; REGRESSION ANALYSIS;

EID: 84881409142     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.121500     Document Type: Article

References (42)

1. Gladman DD. Psoriatic arthritis. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, et al, editors. Kelly's textbook of rheumatology. 7th ed. Philadelphia: W.B. Saunders Co.; 2004:1155-64.
2. Dhir V, Aggarwal A. Psoriatic arthritis: a critical review. Clin Rev Allerg Immunol 2013;44:141-8.
3. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA)-an analysis of 220 patients. Q J Med 1987;62:127-41.
4. Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001;45:151-8.
5. Kane D, Stafford L, Bresnihan B, Fitzgerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003;42:1460-8.
6. McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology 2003;42:778-83.
7. Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003;62:68-70.
8. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28:1842-6.
9. Borman P, Toy GG, Babaoglu S, Bodur H, Ciliz D, Alli N. A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis. Clin Rheumatol 2007;26:330-4.
10. Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 2009;7:25.
11. Lee S, Mendelsohn A, Sarnes E. The burden of psoriatic arthritis: a literature review from a global health systems perspective. Pharm Therapeut 2010;35:680-9.
12. Wallenius M, Skomsvoll JF, Koldingsnes W, Rodevand E, Mikkelsen K, Kaufmann C, et al. Work disability and health-related quality of life in males and females with psoriatic arthritis. Ann Rheum Dis 2009;68:685-9.
13. Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mork C, et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 2002;82:108-13.
14. Hu SW, Holt EW, Husni ME, Qureshi AA. Willingness-to-pay preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study. Semin Arthritis Rheum 2010;39:384-97.
15. Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 2011;63:1729-35.
16. Kimhi O, Caspi D, Bornstein NM, Maharshak N, Gur A, Arbel Y, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 2007;36:203-9.
17. Tam LS, Tomlinson B, Chu TT, Leung YY, Kwok LW, Li TK, et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls-the role of inflammation. Rheumatology 2008;47:718-23.
18. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167-72.
19. Ciocon DH, Horn EJ, Kimball AB. Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only: results of the 2005 Spring US National Psoriasis Foundation Survey. Am J Clin Dermatol 2008;9:111-7.
20. Christophers E, Barker JN, Griffiths CE, Dauden E, Milligan G, Molta C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol 2010;24:548-54.
21. Husni ME, Mease PJ. Managing comorbid disease in patients with psoriatic arthritis. Curr Rheumatol Rep 2010;12:281-7.
22. Kimball AB, Gladman DD, Gelfand JM, Gordon K, Horn EJ, Korman NJ, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008;58:1031-42.
23. Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 2009;68:1131-5.
24. Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92.
25. Ahlehoff O, Gislason GH, Charlot M, Jorgensen CH, Lindhardsen J, Olesen JB, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011;270:147-57.
26. Kimball AB, Bensimon AG, Guerin A, Yu AP, Wu EQ, Okun MM, et al. Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial. Am J Clin Dermatol 2011;12:51-62.
27. Rijken M, van Kerkhof M, Dekker J, Schellevis FG. Comorbidity of chronic diseases. Qual Life Res 2005;14:45-55.
28. Verbrugge LM, Lepkowski JM, Imanaka Y. Comorbidity and its impact on disability. Milbank Q 1989;67:450-84.
29. Merikangas KR, Ames M, Cui L, Stang PE, Ustun TB, von Korff M, et al. The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch Gen Psychiatry 2007;64:1180-8.
30. Girolomoni G, Gottlieb A. Focus on psoriatic arthritis and comorbidities. Exp Rev Dermatol 2008;3 Suppl:S35-6.
31. Schmieder A, Schaarschmidt ML, Umar N, Terris DD, Goebeler M, Goerdt S, et al. Comorbidities significantly impact patients' preferences for psoriasis treatments. J Am Acad Dermatol 2012;67:363-72.
32. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
33. Chandran V, Schentag CT, Gladman DD. Sensitivity of the Classification of Psoriatic Arthritis (CASPAR) Criteria in early psoriatic arthritis. Arthritis Care Res 2007;57:1560-3.
34. Ware JE, Sherbourne CD. The MOS 36-item Short-form Health Survey (SF-36): conceptual framework and item selection. Med Care 1992;30:473-83.
35. Rohekar S, Tom BD, Hassa A, Schentag CT, Farewell VT, Gladman DD. Prevalence of malignancy in psoriatic arthritis. Arthritis Rheum 2008;58:82-7.
36. Marks R, Barton SP, Shuttleworth D, Finlay AY. Assessment of disease progression in psoriasis. Arch Dermatol 1989;125:235-40.
37. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user manual. Boston: New England Medical Center, The Health Institute; 1994.
38. Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ. Validating the SF-36 Health Survey Questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511-7.
39. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures. A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999;15:141-55.
40. Rupp I, Boshuizen HC, Jacobi CE, Dinant HJ, van den Bos G. Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. J Rheumatol 2004;31:58-65.
41. Davis JA, Robinson RL, Le TK, Xie J. Incidence and impact of pain conditions and comorbid illnesses. J Pain Res 2011;4:331-45.
42. Zisman D, Eder L, Elias M, Laor A, Bitterman H, Rozenbaum M, et al. Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel. Rheumatol Int 2012;32:595-600.